| Structure | Chemical Name | CAS | MF |
|
ARG-PRO-LYS-PRO-GLN-GLN-PHE-PHE-PRO-LEU-MET-NH2
|
104486-69-3
|
C66H102N18O13S
|
|
L-glycero-α-D-manno-Heptopyranose 1,2,3,4,6,7-Hexaacetate
|
104486-80-8
|
C19H26O13
|
|
L-talo-Non-2-enonicacid,5,9-anhydro-2,3,4,8-tetradeoxy-8-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]-2-oxiranyl]methyl]-3-methyl-,8-carboxyoctyl ester, calcium salt (2:1), (2E)-
|
104486-81-9
|
C26H46CaO9
|
|
(2RS,3RS)-3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one
|
104486-98-8
|
C15H12O6
|
|
Phenol, 2-(2H-benzotriazol-2-yl)-4-methyl-6-tetracosyl-
|
104487-30-1
|
C37H59N3O
|
|
1,8-DIMETHYLNAPHTHALENE-D12
|
104489-29-4
|
C12D12
|
|
C.I. Solvent Black 49
|
104491-88-5
|
|
|
|
C.I. Sulphur Blue 4
|
104491-89-6
|
|
|
adecypenol
|
104493-13-2
|
C12H16N4O4
|
|
BROUSSOFLAVONOLC
|
104494-29-3
|
|
|
2-[6-(1,1-Dimethyl-2-propenyl)-8-hydroxy-2,2-dimethyl-2H-1-benzopyran-5-yl]-3,5,7-trihydroxy-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one
|
104494-30-6
|
|
|
8-Methoxycarbonyloctanoyl2,3,4,6-tetra-O-acetyl-b-D-galactopyranoside
|
104494-93-1
|
C24H38O12
|
|
2-[4-[Bis(2-acetoxyethyl)amino]phenylazo]-5,6-dichlorobenzothiazole
|
104495-87-6
|
C21H20Cl2N4O4S
|
|
2-(pyridin-2-ylthio)acetohydrazide
|
104496-91-5
|
C7H9N3OS
|
|
4-ethyl-1H-1,2,3-triazole-5-carboxylic acid
|
104497-05-4
|
C5H7N3O2
|
|
6-aminodihydro-1,3-dimethyl-2,4(1H,3H) –pyrimidinedione
|
104497-09-8
|
C6H11N3O2
|
|
2,3-DI(P-TOLYL)-5-PHENYLTETRAZOLIUM CHLORIDE
|
104497-77-0
|
C21H19ClN4
|
|
2,3-BIS(4-ETHYLPHENYL)-5-PHENYLTETRAZOLIUM CHLORIDE
|
104497-78-1
|
C23H23ClN4
|
|
2,3-BIS(4-METHOXYPHENYL)-5-PHENYLTETRAZOLIUM CHLORIDE
|
104497-79-2
|
C21H19ClN4O2
|
|
(S)-(-)-4-ISOPROPYL-2-OXAZOLIDINETHIONE
|
104499-08-3
|
C6H11NOS
|
|
N-(4-METHOXYBENZYL)-N'-METHYL-N-2-PYRIDINYL-1,2-ETHANEDIAMINE
|
104499-47-0
|
C16H21N3O
|
|
substance P (5-11), N-alpha-(desamino-3-iodotyrosyl)-8-N-me-Phe-5,6-Asp-
|
104499-96-9
|
C49H63IN8O13S
|
|
Substance P (5-11), asparaginyl(5,6)-methylphenylalanine(8)-
|
104499-97-0
|
C40H56N8O11S
|
|
2,2':5',2''-Terthiophene, 5,5''-diiodo-
|
104499-99-2
|
C12H6I2S3
|
|
1,3-Propanediol, 2-methyl-2-((5-naphthacenylmethyl)amino)-, methanesul fonate (salt)
|
104500-10-9
|
|
|
1,3-Propanediol, 2-((11H-benzo(b)fluoren-5-ylmethyl)amino)-2-methyl-, methanesulfonate (salt)
|
104500-13-2
|
|
|
1,3-Propanediol, 2-((benzo(c)phenanthren-5-ylmethyl)amino)-2-methyl-, methanesulfonate (salt)
|
104500-15-4
|
|
|
1H-Pyrrole-3-carboxaldehyde,1-(2-propynyl)-(9CI)
|
104500-98-3
|
C8H7NO
|
|
1H-Pyrrole-2-carboxaldehyde,1-(2-propynyl)-(9CI)
|
104501-02-2
|
C8H7NO
|
|
1H-Pyrrole-2-carbonitrile, 4-formyl-1-(2-propynyl)- (9CI)
|
104501-05-5
|
C9H6N2O
|
|
1H-Pyrrole-3-carboxaldehyde,1-(1,2-propadienyl)-(9CI)
|
104501-13-5
|
C8H7NO
|
|
1H-Pyrrole-3-carbonitrile, 4-formyl-1-(2-propynyl)- (9CI)
|
104501-28-2
|
C9H6N2O
|
|
1H-Pyrrole-2-carbonitrile, 3-formyl-1-(2-propynyl)- (9CI)
|
104501-29-3
|
C9H6N2O
|
|
2-[(prop-2-yn-1-yl)amino]acetic acid hydrochloride
|
104501-33-9
|
C5H8ClNO2
|
|
1-Trimethylsilyloxy-1-(3-pyridyl)-ethene
|
104501-58-8
|
C10H15NOSi
|
|
Ethanone, 2-hydroxy-1-(3-pyridinyl)- (9CI)
|
104501-59-9
|
C7H7NO2
|
|
2(5H)-FURANONE, 3-BROMO-5-((HEXAHYDRO-1H-AZEPIN-1-YL)METHYL)-4,5-DIMET HYL-
|
104502-49-0
|
|
|
SODIUM3,6,9,12,15,18,21-HEPTAOXATETRATRIAOCTANOATE
|
104503-68-6
|
C27H55NaO9
|
|
4-Pyridinamine,N-methyl-N,3-dinitro-(9CI)
|
104503-82-4
|
C6H6N4O4
|
|
glicentin (1-16)
|
104504-00-9
|
C78H127N25O27
|
|
8,5'-cyclo-2'-deoxyguanosine
|
104504-22-5
|
C10H11N5O4
|
|
HEPATITIS B VIRUS PRE-S REGION (120-145)
|
104504-34-9
|
C135H199N39O38S
|
|
N-Acetyl-α-cyano-p-benzoyl-D,L-phenylalanine, Ethyl Ester
|
104504-38-3
|
C21H20N2O4
|
|
AC-D-BPA-OH
|
104504-42-9
|
C18H17NO4
|
|
BOC-BPA-OH
|
104504-43-0
|
C21H23NO5
|
|
L-4-BENZOYLPHENYLALANINE
|
104504-45-2
|
C16H15NO3
|
|
Benzeneacetic acid, 3-(bromomethyl)-, methyl ester
|
104508-22-7
|
C10H11BrO2
|
|
6-BROMOMETHYL-2-CYANOPYRIDINE
|
104508-24-9
|
C7H5BrN2
|
|
3-(Phenoxymethyl)benzaldehyde
|
104508-27-2
|
C14H12O2
|
|
Ethanone, 1-[5-(1-methylethenyl)-1H-pyrrol-3-yl]- (9CI)
|
104508-45-4
|
C9H11NO
|
|
2H-Benzimidazol-2-one,1-(1-cyclopenten-1-yl)-1,3-dihydro-(9CI)
|
104509-42-4
|
C12H12N2O
|
|
Uracil, 5-acetamido-1,3-dimethyl-6-methylamino- (6CI)
|
104509-81-1
|
C9H14N4O3
|
|
3-((dimethylamino)methyl)-1H-indole-4-carboxylic acid
|
104510-18-1
|
C12H14N2O2
|
|
1H-Benzimidazole-2-carbonitrile,5-methoxy-,N-oxide(9CI)
|
104512-94-9
|
C9H7N3O2
|
|
1H-Benzimidazole-2-carboxaldehyde,5-methoxy-,oxime(9CI)
|
104512-96-1
|
C9H9N3O2
|
|
6,11-Dihydro-3,8,10,12-tetrahydroxy-1-methyl-6,11-dioxo-2-naphthacenecarboxylic acid methyl ester
|
104513-07-7
|
|
|
3-BUTOXY-PROPIONALDEHYDE DIETHYL ACETAL
|
104513-14-6
|
C7H14O2
|
|
N-[2-(6,7-dichloro-5-methoxy-2-methyl-1H-indol-3-yl)ethyl]acetamide
|
104513-29-3
|
C14H16Cl2N2O2
|
|
Bayogenin 3-O-β-D-glucopyranoside
|
104513-86-2
|
C36H58O10
|
|
N-(aminoacetyl)-1-aza-4,7,10-13-tetraoxacyclopentadecane
|
104514-11-6
|
C12H24N2O5
|
|
4-bromo-5-nitrofuran azomethine
|
104514-43-4
|
C5H3BrN2O3
|
|
1,2-DIBROMO-3-CHLORO-BENZENE
|
104514-49-0
|
C6H3Br2Cl
|
|
N-(4-vinyl-1,3-thiazolidin-2-ylidene)phenylamine
|
104514-74-1
|
|
|
2(3H)-Thiazolone, 4-(1-methylethyl)-
|
104514-85-4
|
C6H9NOS
|
|
4,6-Dichloro-2-Methylthieno[2,3-b]pyridine
|
104515-21-1
|
C8H5Cl2NS
|
|
2,3,6,7-TETRAKIS(ETHYLTHIO)TETRATHIAFULVALENE
|
104515-79-9
|
C14H20S8
|
|
Isoxazole, 3-methyl-5-(2-thienyl)- (9CI)
|
104516-55-4
|
C8H7NOS
|
|
2-(5-ISOXAZOLYL)-4-METHYLPHENOL
|
104516-57-6
|
C10H9NO2
|
|
Ethanol, 2-4-ethyl(2-hydroxyethyl)amino-2-nitrophenylamino-
|
104516-93-0
|
C12H19N3O4
|
|
Ethanone, 1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)- (9CI)
|
104516-96-3
|
C10H14O
|
|
Bicyclo2.2.1heptane-2-carbonitrile, 1,3-dimethyl-
|
104516-97-4
|
C10H15N
|
|
Ioversol Related Compound B (50 mg) (N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbamoyl)methoxy]-2,4,6-triiodoisophthalamide)
|
104517-96-6
|
C18H24I3N3O9
|
|
2,5,8,11,14-Pentaoxahexadecane, 16-iodo-
|
104518-24-3
|
C11H23IO5
|
|
1-{2-[2-(2-{2-[2-(2-Bromo-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethoxy}-2-methoxy-ethane
|
104518-25-4
|
C15H31BrO7
|
|
Ethanone, 1-(2,3-dihydro-2-benzofuranyl)-, (S)- (9CI)
|
104518-93-6
|
C10H10O2
|
|
trans-4-Octylcyclohexylmethanol trimethylsilyl ether
|
104519-19-9
|
C18H38OSi
|
|
|
C-Flex
|
104521-01-9
|
|
|
|
Permabond 910
|
104521-52-0
|
|
|
1-(BIS[4-(TRIFLUOROMETHYL)PHENYL]METHYL)PIPERAZINE
|
104523-09-3
|
C19H18F6N2
|
|
Benzoyl chloride, 2-methoxy-3-propyl- (9CI)
|
104524-28-9
|
C11H13ClO2
|
|
[2-(dimethylamino)-3-pyridinyl]methanol(SALTDATA: HCl)
|
104524-65-4
|
C8H12N2O
|
|
1-Dodecyl-4-(phenylthio)benzene
|
104526-45-6
|
C24H34S
|
|
Alanine, 3-amino-, butyl ester
|
104527-41-5
|
C7H16N2O2
|
|
L-Tyrosine, 3-Methoxy-O-Methyl-, ethyl ester
|
104528-83-8
|
C13H19NO4
|
|
(+)-CAMPHANIC ACID CHLORIDE
|
104530-16-7
|
C10H13ClO3
|
|
(S)-3-AMINOTETRAHYDROFURAN
|
104530-79-2
|
C4H9NO
|
|
3-Furanamine, tetrahydro-, (3S)-, 4-methylbenzenesulfonate
|
104530-80-5
|
C11H17NO4S
|
|
N-(1(S)-carboxy-(4-hydroxy-3-iodophenyl)ethyl)-alanylproline
|
104531-07-9
|
C17H21(125I)N2O6
|
|
(1R,3S)-3-[(1Z)-2-Chloro-3,3,3-trifluoro-1-propen-1-yl]-2,2-dimethylcyclopropanecarboxylic Acid
|
104531-15-9
|
C9H10ClF3O2
|
|
L-4-CYANOPHENYLALANINE
|
104531-20-6
|
C10H11ClN2O2
|
|
(2R,3S)-2-AMINO-3-HYDROXY-PENTANOIC ACID
|
104531-21-7
|
C5H11NO3
|
|
Xestin A
|
104532-58-3
|
C26H44O5
|
|
2-Hydroxyquinoline
|
104534-80-7
|
C9H7NO
|
|
BIS(2,2,2-TRIFLUOROETHYL) ITACONATE
|
104534-96-5
|
C9H8F6O4
|
|
4-Amino-3-nitro-5-beta-hydroxyethylaniline
|
104535-30-0
|
|
|
4-AMINO-3-NITRO-5-BETA-HYDROXYPROPYLANILINE
|
104535-31-1
|
C9H13N3O3
|
|
3,4-DIHYDRO-2H-1,4-BENZOXAZIN-7-OL
|
104535-37-7
|
C8H9NO2
|
|
4,5,7,8,10,10a-hexahydro-9H-thieno<2,3-a>quinolizin-9-one
|
104535-60-6
|
C11H13NOS
|
|
Carbonic acid ethyl-3-phenylsulfonyloxychroman-8-yl ester
|
104536-64-3
|
C18H18O7S
|
|
D-Alanine, 2-hydroxy-1-(hydroxymethyl)ethyl ester (9CI)
|
104537-90-8
|
C6H13NO4
|